Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Change in Account Payables (2020 - 2025)

NeuroPace has reported Change in Account Payables over the past 6 years, most recently at -$2.4 million for Q4 2025.

  • Quarterly results put Change in Account Payables at -$2.4 million for Q4 2025, down 408.54% from a year ago — trailing twelve months through Dec 2025 was -$730000.0 (down 208.79% YoY), and the annual figure for FY2025 was -$730000.0, down 208.79%.
  • Change in Account Payables for Q4 2025 was -$2.4 million at NeuroPace, down from -$48000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for NPCE hit a ceiling of $1.1 million in Q4 2023 and a floor of -$2.4 million in Q4 2025.
  • Median Change in Account Payables over the past 5 years was $84500.0 (2021), compared with a mean of $65350.0.
  • Peak annual rise in Change in Account Payables hit 592.23% in 2024, while the deepest fall reached 4090.91% in 2024.
  • NeuroPace's Change in Account Payables stood at $220000.0 in 2021, then skyrocketed by 288.64% to $855000.0 in 2022, then grew by 23.39% to $1.1 million in 2023, then decreased by 26.73% to $773000.0 in 2024, then tumbled by 408.54% to -$2.4 million in 2025.
  • The last three reported values for Change in Account Payables were -$2.4 million (Q4 2025), -$48000.0 (Q3 2025), and $737000.0 (Q2 2025) per Business Quant data.